Predicting Treatment Response of Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder Using an Explainable Machine Learning Model Based on Electroencephalography and Clinical Features
Zongya Zhao , Xiangying Ran , Yanxiang Niu , Mengyue Qiu , Shiyang Lv , Mingjie Zhu , Junming Wang , Mingcai Li , Zhixian Gao , Chang Wang , Yongtao Xu , Wu Ren , Xuezhi Zhou , Xiaofeng Fan , Jinggui Song , Mingchao Qi , Yi Yu
{"title":"Predicting Treatment Response of Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder Using an Explainable Machine Learning Model Based on Electroencephalography and Clinical Features","authors":"Zongya Zhao , Xiangying Ran , Yanxiang Niu , Mengyue Qiu , Shiyang Lv , Mingjie Zhu , Junming Wang , Mingcai Li , Zhixian Gao , Chang Wang , Yongtao Xu , Wu Ren , Xuezhi Zhou , Xiaofeng Fan , Jinggui Song , Mingchao Qi , Yi Yu","doi":"10.1016/j.bpsc.2025.02.002","DOIUrl":null,"url":null,"abstract":"<div><div>Major depressive disorder (MDD) is highly heterogeneous in response to repetitive transcranial magnetic stimulation (rTMS), and identifying predictive biomarkers is essential for personalized treatment. However, most prior research studies have used either electroencephalography (EEG) or clinical features, lack interpretability, or have small sample sizes. This study included 74 patients with MDD who responded (responders) and 43 patients with MDD who did not respond (nonresponders) to rTMS. Eight baseline EEG metrics and clinical features were sent to 7 machine learning models to classify responders and nonresponders. Shapley additive explanations (SHAP) was used to interpret feature contributions. Combining phase locking value and clinical features with support vector machine achieved optimal classification performance (accuracy = 97.33%). SHAP revealed that delta and beta band functional connectivity (F3-P7, F3-P4, P3-P8, T7-Cz) significantly influenced predictions and differed between groups. This study developed an explainable predictive framework to predict rTMS response in MDD, enhancing the accuracy of rTMS response prediction and supporting personalized treatment in MDD.</div></div>","PeriodicalId":54231,"journal":{"name":"Biological Psychiatry-Cognitive Neuroscience and Neuroimaging","volume":"10 6","pages":"Pages 656-665"},"PeriodicalIF":4.8000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological Psychiatry-Cognitive Neuroscience and Neuroimaging","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S245190222500059X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Major depressive disorder (MDD) is highly heterogeneous in response to repetitive transcranial magnetic stimulation (rTMS), and identifying predictive biomarkers is essential for personalized treatment. However, most prior research studies have used either electroencephalography (EEG) or clinical features, lack interpretability, or have small sample sizes. This study included 74 patients with MDD who responded (responders) and 43 patients with MDD who did not respond (nonresponders) to rTMS. Eight baseline EEG metrics and clinical features were sent to 7 machine learning models to classify responders and nonresponders. Shapley additive explanations (SHAP) was used to interpret feature contributions. Combining phase locking value and clinical features with support vector machine achieved optimal classification performance (accuracy = 97.33%). SHAP revealed that delta and beta band functional connectivity (F3-P7, F3-P4, P3-P8, T7-Cz) significantly influenced predictions and differed between groups. This study developed an explainable predictive framework to predict rTMS response in MDD, enhancing the accuracy of rTMS response prediction and supporting personalized treatment in MDD.
期刊介绍:
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging is an official journal of the Society for Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms, and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal focuses on studies using the tools and constructs of cognitive neuroscience, including the full range of non-invasive neuroimaging and human extra- and intracranial physiological recording methodologies. It publishes both basic and clinical studies, including those that incorporate genetic data, pharmacological challenges, and computational modeling approaches. The journal publishes novel results of original research which represent an important new lead or significant impact on the field. Reviews and commentaries that focus on topics of current research and interest are also encouraged.